Showing 21-27 of 27 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Protective Interventions against Loss of Function and Destruction of β cells in Type 1 Diabetes. | Icahn School of Medicine at Mount Sinai | Romina Bevacqua | Cures | 01-March-2026 to 28-February-2031 | $999,999.00 |
| Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. | Icahn School of Medicine at Mount Sinai | Romina Bevacqua | Cures | 01-April-2025 to 31-March-2027 | $559,996.54 |
| Cardiotoxic Circulating Extracellular Vesicles: New Drivers of Type 1 Diabetes-induced Cardiomyopathy | Icahn School of Medicine at Mount Sinai | Susmita Sahoo | Improving Lives | 01-April-2025 to 30-September-2026 | $199,998.24 |
| Stromal Cell Targeted Tolerogenic mRNA Therapy for T1D | Endotope Biosciences | Raymond Liang | Cures | 15-December-2025 to — | $550,417.82 |
| Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults with Type 1 Diabetes | Albert Einstein College of Medicine | Jeffrey Gonzalez | Improving Lives | 01-December-2022 to 30-November-2026 | $1,672,180.00 |
| Telemedicine-Delivered Cognitive Behavioral Therapy to Reduce Diabetes Distress in Young Adults with Type 1 Diabetes (CBT-DD) | Albert Einstein College of Medicine | Jeffrey Gonzalez | Improving Lives | 01-September-2021 to 30-June-2027 | $1,870,600.00 |
| Collaboration for Global T1D Care | Acora | Rebecca Goldman | Mission | 01-December-2025 to 31-January-2027 | $648,500.00 |